Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review
Top Cited Papers
Open Access
- 1 February 2024
- journal article
- review article
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 19, 567-578
Abstract
Most patients with chronic obstructive pulmonary disease (COPD) suffer from at least one additional, clinically relevant chronic disease. To a degree, the high global prevalence and mortality rate of COPD is closely related to its extrapulmonary effects. Moreover, the various of comorbidities of COPD and itself interact with each other, resulting in diverse clinical manifestations and individual differences, and thus further influencing the prognosis as well as healthcare burden of COPD patients. This is closely related to the common risk factors of chronic diseases (aging, smoking, inactivity, etc.). Additionally, some pathophysiological mechanisms caused by COPD, including the systemic inflammatory response, hypoxia, oxidative stress, and others, also have an impact on other systems. But comprehensive management and medical interventions have not yet been established. The clinicians should improve their knowledge and skills in diagnosing as well as treating the comorbidities of COPD, and then aim to develop more individualized, efficient diagnostic and therapeutic strategies for different patients to achieve greater clinical benefits. In this article, we will review the risk factors, mechanisms, and treatment strategies for extrapulmonary comorbidities in chronic obstructive pulmonary disease, including cardiovascular diseases, diabetes, anemia, osteoporosis, emotional disorders, and gastroesophageal reflux disease.Keywords
This publication has 126 references indexed in Scilit:
- Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong KongJAMA Network Open, 2023
- Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2020
- Proton pump inhibitors for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2020
- Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90/NLRP3 interaction and inducing autophagy in ratsInflammopharmacology, 2020
- Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2018
- Inhaled glucocorticoids are associated with vertebral fractures in COPD patientsJournal of Bone and Mineral Metabolism, 2018
- Hypoxia negatively affects senescence in osteoclasts and delays osteoclastogenesisJournal of Cellular Physiology, 2018
- Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary DiseaseLung, 2016
- Bisphosphonates for steroid-induced osteoporosisCochrane Database of Systematic Reviews, 2016
- The association of low bone mineral density with systemic inflammation in clinically stable COPDEndocrine, 2011